BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21192264)

  • 1. Economic considerations of the diagnosis and management for glaucoma in the developed world.
    Tuulonen A
    Curr Opin Ophthalmol; 2011 Mar; 22(2):102-9. PubMed ID: 21192264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on 'What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model'.
    Papalkar D; Francis IC; Lim R
    Clin Exp Ophthalmol; 2005 Aug; 33(4):446; author reply 447. PubMed ID: 16033375
    [No Abstract]   [Full Text] [Related]  

  • 3. Glaucoma care cost-effectiveness.
    Hoskins HD
    Ophthalmology; 2009 May; 116(5):1016. PubMed ID: 19410965
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the direct cost of treatment of acute primary angle closure glaucoma? The Singapore model.
    Wang JC; Chew PT
    Clin Exp Ophthalmol; 2004 Dec; 32(6):578-83. PubMed ID: 15575827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
    Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
    J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations in developing model-based economic evaluations of glaucoma treatment.
    Althin R; Grima DT; Dhawan R; Bernard LM
    J Glaucoma; 2006 Dec; 15(6):541-7. PubMed ID: 17106369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma costs in Denmark in treatment naive patients.
    Olsen J; Berdeaux G; Skov J
    Acta Ophthalmol; 2013 Feb; 91(1):25-31. PubMed ID: 21834919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness: insights on treatment options for open-angle glaucoma.
    Morse AR; Lee PP
    Arch Ophthalmol; 2012 Apr; 130(4):506-7. PubMed ID: 22491919
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the socio-economic relevance of glaucoma].
    Grüb M; Rohrbach JM
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):793-5. PubMed ID: 17063419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma screening: current trends, economic issues, technology, and challenges.
    Nduaguba C; Lee RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):142-52. PubMed ID: 16552249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is more always better?
    Tuulonen A
    Acta Ophthalmol Scand; 2004 Aug; 82(4):377-9. PubMed ID: 15291927
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glaucoma: cardinal problems, opportunities].
    Nesterov AP
    Vestn Oftalmol; 2008; 124(1):3-5. PubMed ID: 18318198
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care.
    Fukuda Y; Kume A; Kashiwagi K
    Curr Eye Res; 2021 Nov; 46(11):1695-1702. PubMed ID: 33843390
    [No Abstract]   [Full Text] [Related]  

  • 16. Glaucoma: where to now?
    Taylor HR
    Ophthalmology; 2009 May; 116(5):821-2. PubMed ID: 19410940
    [No Abstract]   [Full Text] [Related]  

  • 17. New glaucoma diagnostic technologies: a systematic review of economic studies.
    Tarride JE; Burke N; Hopkins RB; Goeree R; Hodge WG
    Can J Ophthalmol; 2011 Feb; 46(1):89-90. PubMed ID: 21283168
    [No Abstract]   [Full Text] [Related]  

  • 18. The medicare glaucoma screening benefit: a critical program that misses its target.
    Gower EW; Whiteside-de Vos J; Cassard SD; Shekhawat NS; Friedman DS
    Am J Ophthalmol; 2013 Aug; 156(2):211-212.e2. PubMed ID: 23870357
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic impact of primary open-angle glaucoma in Australia.
    Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
    Clin Exp Ophthalmol; 2011; 39(7):623-32. PubMed ID: 21631669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing healthcare costs: can we influence the costs of glaucoma care?
    Töteberg-Harms M; Berlin MS; Meier-Gibbons F
    Curr Opin Ophthalmol; 2017 Mar; 28(2):127-132. PubMed ID: 27828895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.